Risk factors for non-adherence to medication in inflammatory bowel disease patients

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2008, Pages 166-172

  D'Inca R ^a,b   Bertomoro, P ^b   Mazzocco, K ^b   Vettorato, M G ^b   Rumiati, R ^b   Sturniolo, G C ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DOCTOR PATIENT RELATION; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECALL; REMISSION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; TREATMENT INDICATION; TREATMENT OUTCOME; WORK SCHEDULE;

ADOLESCENT; ADULT; AGED; EPIDEMIOLOGIC FACTORS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; SEX FACTORS; TREATMENT REFUSAL;

EID: 37149053152     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03555.x     Document Type: Article

References (33)

1. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990 74 : 39 50.
2. Levine JB. Extraintestinal manifestations of inflammatory bowel disease. In : Kirsner JB, ed. Inflammatory Bowel Disease, 5th edn. Philadelphia, PA : WB Saunder, 2000 : 397 409.
3. Eaden J, Abrams K, Ekbon A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case control study. Aliment Pharmacol Ther 2003 17 : 1207 14.
4. Rutter M, Saunders B, Wilkinson K. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004 118 : 671 4.
5. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005 11 : 314 21.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353 : 487 97.
7. Kane SV. Adherence issues in management of inflammatory bowel disease. In : Bayless TM, Hanauer SB, eds. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, BC : Decker Inc., 2001 : pp. 9 11.
8. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004 53 : 1471 8.
9. Farup P, Hinterleitner T, Lukas M. Mesalazine 4 gr daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm Bowel Dis 2001 7 : 237 42.
10. Hanauer SB, Sninsky CA, Robinson M. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis: a randomized, placebo-controlled trial. Ann Intern Med 1996 124 : 204 11.
11. Prantera C, Viscido A, Biancone L, et al. A new oral delivery system for 5 ASA: preliminary clinical findings for MMX. Inflamm Bowel Dis 2005 11 : 421 7.
12. Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003 18 : 191 8.
13. Kane S, Huo D, Aikens J, Hanauer S. Medication non-adherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003 114 : 39 43.
14. Kane S, Cohen RD, Aikens JE, Hanauer S. Prevalence of non-adherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001 96 : 2929 33.
15. Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimes. Am J Gastroenterol 1999 94 : 1733 42.
16. Kane S, Dixon L. Adherence rates with infliximab therapy in Crohn's disease. Aliment Pharmacol Ther 2006 24 : 1099 103.
17. Bernal I, Domenech E, Garcia-Planella E, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006 51 : 2165 9.
18. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990 150 : 1509 10.
19. Kane S. Medication adherence and the physician-patient relationship. Am J Gastroenterol 2002 97 (Suppl. 7 1853.
20. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007 102 : 1 10.
21. Gionchetti P, Ardizzone S, Benvenuti ME, et al. A new mesalazine gel enema in the treatment of left-side ulcerative colitis: a randomized controlled multicentre trial. Aliment Pharmacol Ther 1999 13 : 381 8.
22. Kane S, Hanauer SB. National adherence rates with IBD therapy: PO vs PR [abstract]. Am J Gastroenterol 2001 96 : S296.
23. Kane S, Huo D, Magnanti K. A pilot feasibility study of once-daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003 1 : 170 3.
24. Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer 1986 58 : 1179 84.
25. Friedman IM, Litt IF, King DR, et al. Compliance with anticonvulsant therapy by epileptic youth: relationships to psychosocial aspects of adolescent development. J Adolesc Health Care 1986 7 : 12 7.
26. Friedman IM, Litt IF. Adolescents' compliance with therapeutic regimens: psychological and social aspects and intervention. J Adolesc Health Care 1987 8 : 52 67.
27. Michaud PA, Suris JC, Viner R. The adolescent with a chronic condition. Part II: Healthcare provision. Arch Dis Child 2004 89 : 943 9.
28. Berry D, Bradlow A, Bersellini E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology 2004 43 : 901 5.
29. Barber N, Parson J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care 2004 13 : 172 5.
30. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GA, Cohen A. Patient non-adherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003 98 : 1535 44.
31. Stewart MA. Effective physician-patient communication and health outcome: a review. CMAJ 1995 152 (Suppl. 9 1423 33.
32. Trummer UF, Mueller UO, Nowak P. Does physician-patient communication that aims at empowering patients improve clinical outcome? A case study. Patient Educ Couns 2006 61 : 299 306.
33. Bokemeyer B, Teml A, Roggel C, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther 2007 26 : 217 25.